Cargando…

The role of interferons in ovarian cancer progression: Hinderer or promoter?

Ovarian cancer (OC) is a common gynecologic malignancy with poor prognosis and high mortality. Changes in the OC microenvironment are closely related to the genesis, invasion, metastasis, recurrence, and drug-resistance. The OC microenvironment is regulated by Interferons (IFNs) known as a type of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Taiqing, Li, Yinqi, Wang, Xiaoyu, Yang, Xiaodong, Fu, Yunhai, Zheng, Yeteng, Gong, Hanlin, He, Zhiyao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810991/
https://www.ncbi.nlm.nih.gov/pubmed/36618371
http://dx.doi.org/10.3389/fimmu.2022.1087620
_version_ 1784863432258879488
author Liu, Taiqing
Li, Yinqi
Wang, Xiaoyu
Yang, Xiaodong
Fu, Yunhai
Zheng, Yeteng
Gong, Hanlin
He, Zhiyao
author_facet Liu, Taiqing
Li, Yinqi
Wang, Xiaoyu
Yang, Xiaodong
Fu, Yunhai
Zheng, Yeteng
Gong, Hanlin
He, Zhiyao
author_sort Liu, Taiqing
collection PubMed
description Ovarian cancer (OC) is a common gynecologic malignancy with poor prognosis and high mortality. Changes in the OC microenvironment are closely related to the genesis, invasion, metastasis, recurrence, and drug-resistance. The OC microenvironment is regulated by Interferons (IFNs) known as a type of important cytokines. IFNs have a bidirectional regulation for OC cells growth and survival. Meanwhile, IFNs positively regulate the recruitment, differentiation and activation of immune cells. This review summarizes the secretion and the role of IFNs. In particular, we mainly elucidate the actions played by IFNs in various types of therapy. IFNs assist radiotherapy, targeted therapy, immunotherapy and biotherapy for OC, except for some IFN pathways that may cause chemo-resistance. In addition, we present some advances in OC treatment with the help of IFN pathways. IFNs have the ability to powerfully modulate the tumor microenvironment and can potentially provide new combination strategies for OC treatment.
format Online
Article
Text
id pubmed-9810991
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98109912023-01-05 The role of interferons in ovarian cancer progression: Hinderer or promoter? Liu, Taiqing Li, Yinqi Wang, Xiaoyu Yang, Xiaodong Fu, Yunhai Zheng, Yeteng Gong, Hanlin He, Zhiyao Front Immunol Immunology Ovarian cancer (OC) is a common gynecologic malignancy with poor prognosis and high mortality. Changes in the OC microenvironment are closely related to the genesis, invasion, metastasis, recurrence, and drug-resistance. The OC microenvironment is regulated by Interferons (IFNs) known as a type of important cytokines. IFNs have a bidirectional regulation for OC cells growth and survival. Meanwhile, IFNs positively regulate the recruitment, differentiation and activation of immune cells. This review summarizes the secretion and the role of IFNs. In particular, we mainly elucidate the actions played by IFNs in various types of therapy. IFNs assist radiotherapy, targeted therapy, immunotherapy and biotherapy for OC, except for some IFN pathways that may cause chemo-resistance. In addition, we present some advances in OC treatment with the help of IFN pathways. IFNs have the ability to powerfully modulate the tumor microenvironment and can potentially provide new combination strategies for OC treatment. Frontiers Media S.A. 2022-12-21 /pmc/articles/PMC9810991/ /pubmed/36618371 http://dx.doi.org/10.3389/fimmu.2022.1087620 Text en Copyright © 2022 Liu, Li, Wang, Yang, Fu, Zheng, Gong and He https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Liu, Taiqing
Li, Yinqi
Wang, Xiaoyu
Yang, Xiaodong
Fu, Yunhai
Zheng, Yeteng
Gong, Hanlin
He, Zhiyao
The role of interferons in ovarian cancer progression: Hinderer or promoter?
title The role of interferons in ovarian cancer progression: Hinderer or promoter?
title_full The role of interferons in ovarian cancer progression: Hinderer or promoter?
title_fullStr The role of interferons in ovarian cancer progression: Hinderer or promoter?
title_full_unstemmed The role of interferons in ovarian cancer progression: Hinderer or promoter?
title_short The role of interferons in ovarian cancer progression: Hinderer or promoter?
title_sort role of interferons in ovarian cancer progression: hinderer or promoter?
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810991/
https://www.ncbi.nlm.nih.gov/pubmed/36618371
http://dx.doi.org/10.3389/fimmu.2022.1087620
work_keys_str_mv AT liutaiqing theroleofinterferonsinovariancancerprogressionhindererorpromoter
AT liyinqi theroleofinterferonsinovariancancerprogressionhindererorpromoter
AT wangxiaoyu theroleofinterferonsinovariancancerprogressionhindererorpromoter
AT yangxiaodong theroleofinterferonsinovariancancerprogressionhindererorpromoter
AT fuyunhai theroleofinterferonsinovariancancerprogressionhindererorpromoter
AT zhengyeteng theroleofinterferonsinovariancancerprogressionhindererorpromoter
AT gonghanlin theroleofinterferonsinovariancancerprogressionhindererorpromoter
AT hezhiyao theroleofinterferonsinovariancancerprogressionhindererorpromoter
AT liutaiqing roleofinterferonsinovariancancerprogressionhindererorpromoter
AT liyinqi roleofinterferonsinovariancancerprogressionhindererorpromoter
AT wangxiaoyu roleofinterferonsinovariancancerprogressionhindererorpromoter
AT yangxiaodong roleofinterferonsinovariancancerprogressionhindererorpromoter
AT fuyunhai roleofinterferonsinovariancancerprogressionhindererorpromoter
AT zhengyeteng roleofinterferonsinovariancancerprogressionhindererorpromoter
AT gonghanlin roleofinterferonsinovariancancerprogressionhindererorpromoter
AT hezhiyao roleofinterferonsinovariancancerprogressionhindererorpromoter